Pharma's Almanac: Nice Insight's Content Community

ad image

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Chemotherapy

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2025 PHARMA’S ALMANAC. All rights reserved.

1 / 1

Modernizing Dated Approaches to Oncology Care

Chemotherapy

Modernizing Dated Approaches to Oncology Care

FivepHusion

PAO-11-24-RTM-01Nov 06, 2024

Recovering from Cancer Treatment May Get Easier

Recovering from Cancer Treatment May Get Easier

David Alvaro, Ph.D.

Pharma's Almanac

PA2186Aug 27, 2019

Roche

FDA Approval

FDA Approves Roche's Tecentriq in Combination with Avastin and Chemotherapy for the Initial Treatment of People with a Specific Type of Metastatic Lung Cancer

Roche

PR-M12-18-NI-041Dec 12, 2018

Harvard University Researchers Develop Ultrasound/Nanoparticle Method for Targeted Delivery of Chemotherapeutics

Drug Delivery

Harvard University Researchers Develop Ultrasound/Nanoparticle Method for Targeted Delivery of Chemotherapeutics

Emilie Branch

Pharma's Almanac

PAO-M06-17-NI-015Jun 23, 2017

Modeling Patient-Specific Kidney Diseases by Combining Engineered Stem Cells and Chip Technology

Innovation

Modeling Patient-Specific Kidney Diseases by Combining Engineered Stem Cells and Chip Technology

Emilie Branch

Pharma's Almanac

PAO-M05-17-NI-018May 19, 2017

1 / 1